Cargando…

Ketamine and esketamine in suicidal thoughts and behaviors: a systematic review

BACKGROUND: More than 2% of the general population experience suicidal ideas each year and a large number of them will attempt suicide. Evidence-based therapeutic options to manage suicidal crisis are currently limited. OBJECTIVES: The aim of this study was to overview the findings on the use of ket...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jollant, Fabrice, Colle, Romain, Nguyen, Thi Mai Loan, Corruble, Emmanuelle, Gardier, Alain M., Walter, Martin, Abbar, Mocrane, Wagner, Gerd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912570/ https://www.ncbi.nlm.nih.gov/pubmed/36776623 http://dx.doi.org/10.1177/20451253231151327

Ejemplares similares

Pharmacological Mechanism of Ketamine in Suicidal Behavior Based on Animal Models of Aggressiveness and Impulsivity: A Narrative Review
por: Nguyen, Thi Mai Loan, et al.
Publicado: (2023)

Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial
por: Abbar, Mocrane, et al.
Publicado: (2022)

Group Post-Admission Cognitive Therapy for Suicidality vs Individual Supportive Therapy for the prevention of repeat suicide attempts: a randomized controlled trial
por: Chaïb, Laurent S., et al.
Publicado: (2020)

Intra-nasal Esketamine Induced Psychotic Disorder in a Post Covid-19 Major Depressive Episode: a case report
por: Tang, Julie, et al.
Publicado: (2023)

Esketamine/ketamine for treatment-resistant depression
por: Lacerda, Acioly L.T.
Publicado: (2020)

Differential Peripheral Proteomic Biosignature of Fluoxetine Response in a Mouse Model of Anxiety/Depression
por: Mendez-David, Indira, et al.
Publicado: (2017)

Investigating the Clinical Profile of Suicide Attempters Who Used a Violent Suicidal Means
por: Lübbert, Marlehn, et al.
Publicado: (2022)

How effective are ketamine or esketamine in treatment-resistant depression?
por: Veluri, N., et al.
Publicado: (2021)

Neuroimaging-informed phenotypes of suicidal behavior: a family history of suicide and the use of a violent suicidal means
por: Jollant, Fabrice, et al.
Publicado: (2018)

The Impact of Infectious Disease-Related Public Health Emergencies on Suicide, Suicidal Behavior, and Suicidal Thoughts: A Systematic Review
por: Zortea, Tiago C., et al.
Publicado: (2020)

Esketamine Anesthetizes Mice With a Similar Potency to Racemic Ketamine
por: Ma, Xiaofan, et al.
Publicado: (2023)

Psychiatric disorders and long COVID
por: Gasnier, Matthieu, et al.
Publicado: (2022)

Esketamine may be an ideal substitute for ketamine during cochlear function measurement
por: Li, Yufeng, et al.
Publicado: (2021)

The TRKB rs2289656 genetic polymorphism is associated with acute suicide attempts in depressed patients: A transversal case control study
por: Deflesselle, Eric, et al.
Publicado: (2018)

128. Long Covid and Psychiatric Disorders 4 Months After a Hospitalization for COVID-19: A Cross Sectional Study
por: Gasnier, Matthieu, et al.
Publicado: (2023)

Telemedicine use during the COVID-19 lockdown is associated with fewer depressive symptoms among physicians in private practice
por: Frajerman, Ariel, et al.
Publicado: (2023)

Acute Effects of Intravenous Sub-Anesthetic Doses of Ketamine and Intranasal Inhaled Esketamine on Suicidal Ideation: A Systematic Review and Meta-Analysis
por: Chen, Cheng-Chuan, et al.
Publicado: (2023)

Peripheral proteomic changes after electroconvulsive seizures in a rodent model of non-response to chronic fluoxetine
por: Lebeau, Rodolphe H., et al.
Publicado: (2022)

Connectomics-Based Functional Network Alterations in both Depressed Patients with Suicidal Behavior and Healthy Relatives of Suicide Victims
por: Wagner, Gerd, et al.
Publicado: (2019)

Hospitalization for self-harm during the early months of the COVID-19 pandemic in France: A nationwide retrospective observational cohort study
por: JOLLANT, Fabrice, et al.
Publicado: (2021)

SARS-CoV-2 Infection and the Risk of Suicidal and Self-Harm Thoughts and Behaviour: A Systematic Review
por: Sinyor, Mark, et al.
Publicado: (2022)

Structural brain alterations associated with suicidal thoughts and behaviors in young people: results from 21 international studies from the ENIGMA Suicidal Thoughts and Behaviours consortium
por: van Velzen, Laura S., et al.
Publicado: (2022)

“Esketamine” in Borderline Personality Disorder: A Look Beyond Suicidality
por: Nandan, Neethu K, et al.
Publicado: (2022)

Santé mentale des médecins libéraux français pendant la deuxième vague de COVID 19
por: Frajerman, Ariel, et al.
Publicado: (2023)

Functional network alterations differently associated with suicidal ideas and acts in depressed patients: an indirect support to the transition model
por: Wagner, Gerd, et al.
Publicado: (2021)

Liver Function Test Abnormalities in Depressed Patients Treated with Antidepressants: A Real-World Systematic Observational Study in Psychiatric Settings
por: Voican, Cosmin Sebastian, et al.
Publicado: (2016)

Acute Effects of Intravenous Sub-Anesthetic Doses of Ketamine and Intranasal Inhaled Esketamine on Suicidal Ideation: A Systematic Review and Meta-Analysis: Letter in Response [Letter]
por: Manu, Lucian
Publicado: (2023)

The experience of social exclusion in women with a history of suicidal acts: a neuroimaging study
por: Olié, Emilie, et al.
Publicado: (2017)

Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study
por: Laanani, Moussa, et al.
Publicado: (2023)

Acute Effects of Intravenous Sub-Anesthetic Doses of Ketamine and Intranasal Inhaled Esketamine on Suicidal Ideation: A Systematic Review and Meta-Analysis: Letter in Response [Response to Letter]
por: Chen, Cheng-Chuan, et al.
Publicado: (2023)

Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness
por: Llorca, Pierre Michel, et al.
Publicado: (2013)

Association of the delayed changes in glutamate levels and functional connectivity with the immediate network effects of S-ketamine
por: Danyeli, Lena Vera, et al.
Publicado: (2023)

Esketamine versus placebo on time to remission in major depressive disorder with acute suicidality
por: Fu, Dong-Jing, et al.
Publicado: (2023)

Correction: Association of the delayed changes in glutamate levels and functional connectivity with the immediate network effects of S-ketamine
por: Danyeli, Lena Vera, et al.
Publicado: (2023)

Comparative study of esketamine and racemic ketamine in treatment-resistant depression: Protocol for a non-inferiority clinical trial
por: Correia-Melo, Fernanda S., et al.
Publicado: (2018)

Third-generation cognitive behavioral therapy versus treatment-as-usual for attention deficit and hyperactivity disorder: a multicenter randomized controlled trial
por: Crouzet, Laetitia, et al.
Publicado: (2022)

Computerized-Adaptive vs. Traditional Ratings of Depression and Suicidal Thoughts: An Assay Sensitivity Pilot Study in a Ketamine Clinical Trial
por: Grunebaum, Michael F., et al.
Publicado: (2021)

The MAOA rs979605 Genetic Polymorphism Is Differentially Associated with Clinical Improvement Following Antidepressant Treatment between Male and Female Depressed Patients
por: Chappell, Kenneth, et al.
Publicado: (2022)

Ketamine and Lamotrigine Combination in Psychopharmacology: Systematic Review
por: Wilkowska, Alina, et al.
Publicado: (2022)

A method for biomarker measurements in peripheral blood mononuclear cells isolated from anxious and depressed mice: β-arrestin 1 protein levels in depression and treatment
por: Mendez-David, Indira, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9cd4t3ealhtl0t2dg0qd6lu6re